logo
* 搜尋
* 核能資訊中心
* 中心簡介
* 日本福島核災專區
* 相關資訊
國際核能現況 : BWXT announces new Mo-99 technology
發表人 nicenter 於 2018/5/9 14:26:56 (17 人讀取)

BWX Technologies Inc (BWXT) has developed an innovative process developed to manufacture molybdenum-99 (Mo-99) which it says is a breakthrough for medical radioisotope manufacturing technology. The company plans to introduce the technology by the end of 2019, subject to regulatory approvals.





BWXT's prototype Tc-99m generator (Image: BWXT)


Featuring a patent-pending neutron capture process, BWXT's technology produces Mo-99, the parent isotope of technetium-99m (Tc-99m), which is used globally in more than 30 million medical procedures each year. BWXT's process will produce Mo-99 from natural molybdenum, rather than enriched uranium targets, which the company says eliminates fission waste, reduces environmental impacts and eliminating proliferation risk.


The Mo-99 will be housed in BWXT-manufactured Tc-99m generators, from which Tc-99m will be extracted for medical imaging and diagnostic procedures. The generators are still under development.


Tc-99m is the most widely used radionuclide for medical imaging, but as it has a short half-life.Both it and the Mo-99 it is generated from have to be used quickly once they are produced and a constant, stable supply of them is needed. Mo-99 has primarily been produced by a limited number of research reactors, many of which have been operating since the 1960s, and at times supply has been subject to disruptions and significant radioisotope shortages following outages at those reactors.


Speaking to investors yesterday, BWXT President and CEO Rex Geveden described the current Mo-99 manufacturing infrastructure, with no production at all in North America, as inefficient, globally dispersed and "extremely aged", with "burdensome" logistics. He said BWXT's breakthrough technology addresses all the problems of an expensive, unstable supply producing complex radioactive waste streams, with an associated proliferation risk.


The company anticipates entering the market through generator sales to radiopharmacies, initially focusing on the North American market where it says it will have sufficient production capacity to satisfy all Mo-99 demand.


"We are presently working to finalise agreements that will provide us with a long-term and stable irradiation supply of Mo-99 and other medical radioisotopes from multiple sources," Geveden said.


The Tc-99m generators, which will require approval by the US Food and Drug Administration (FDA), are being designed to integrate "naturally" into the existing configurations and processes of radiopharmacies to be a "plug and play" solution, with no special hardware or adaptation needed.


BWXT in April signed a definitive agreement to acquire Sotera Health's Nordion medical isotope business, to accelerate and de-risks its entry into the medical radioisotope market by adding licensed infrastructure, about 150 highly trained and experienced personnel, and two production centres. Subject to Canadian and US regulatory approvals, the acquisition is expected to close by the end of 2018.


Geveden said BWXT intends to use the assets from the acquisition to bring the Mo-99 product through the commercialisation stage and the BWXT technetium generators through the FDA approval process. It plans to adapt the two licensed production facilities included in the acquisition to process molybdenum targets and produce technetium generators.


Researched and written
by World Nuclear News



source:http://www.world-nuclear-news.org/RS-BWXT-announces-new-Mo-99-technology-0805187.html



其他新聞
2018/5/25 14:30:00 - 夏月電價6月1日起跑 台電邀全民節電
2018/5/25 14:15:30 - The German government approved a draft law on 23 May 2018 that paves the way for energy giants RWE and Vattenfall to receive hundreds of millions of euros in compensation for the country’s decision to phase out nuclear power.
2018/5/25 14:13:59 - Germany to compensate utilities for nuclear phaseout losses
2018/5/25 14:12:57 - Alliance launched to highlight nuclear on world stage
2018/5/23 14:20:00 - 綠能創新 全台首座離島大型微電網誕生澎湖七美
2018/5/23 14:18:31 - UK Nuclear Industry Welcomes PM’s Plan To Seek Euratom Associate Status
2018/5/23 14:16:55 - Japanese utility seeks to start up new reactor
2018/5/23 14:14:18 - Supreme Court to consider Virginia uranium ban
2018/5/18 15:10:00 - Belgium and China award simulator contracts
2018/5/18 15:09:56 - 有關韓國電力公社(KEPCO)旗下核燃料廠爆炸案,據悉目前無輻射外洩,本會持續查證中
2018/5/18 15:08:34 - Foratom Boss: EU Is In Danger Of Overlooking The Long-Term Benefits Of Nuclear
2018/5/18 15:06:47 - DR Congo research reactor requires improvement, says IAEA
2018/5/16 14:19:36 - 節電就可不蓋電廠? 台電:嚴重誤導 開源節流都重要
2018/5/16 14:17:48 - IAEA Mission Reviews Afghanistan’s Cancer Care Needs
2018/5/16 14:16:56 - NWMO broadens its international cooperation
2018/5/16 14:13:57 - Rising: Nuclear surge builds sustainable energy mix
2018/5/11 14:38:01 - 台電努力維持今年供電穩定 明年達成法定備用容量率目標
2018/5/11 14:35:49 - Perry Urges Saudi Arabia To Sign Nuclear Agreement With US
2018/5/11 14:34:50 - UK seeks to improve decommissioning policy
2018/5/11 14:32:27 - Nuclear for US grid resilience and climate

 線上期刊目錄

 瀏覽人數
今天: 25
昨天: 117
本月: 2591
總計: 522705

30013 新竹市光復路二段101號 創新育成中心三樓309室 電話:(03)571-1808 傳真:(03)572-5461 Email: nicenter@nicenter.org.tw